Tenaya Therapeutics · 2 months ago
Associate Scientist/Manager, Translational Medicine
South San Francisco, CA
Full-time
Onsite
Mid, Senior Level
$120K/yr - $170K/yr
6+ years expTenaya Therapeutics is a clinical-stage biotechnology company focused on developing curative therapies for heart disease. They are seeking an experienced Associate Scientist/Manager in Translational Medicine to manage biomarker sample operations and assay development for heart failure gene therapy. This role involves collaborating across functions to ensure high-quality biomarker sample results are delivered for drug development decisions.
BiopharmaBiotechnologyHealth CareTherapeutics
Responsibilities
Manage sample logistics and operations for biomarker sample analysis, collaborating with study management team, central laboratory, specialty lab vendors and data management team
Contribute to nonclinical and clinical trial documents including sample collection sections of study protocols, central laboratory specifications and laboratory manuals, data transfer agreements and study reports
Work with program management and clinical teams to create and manage timelines for biomarker data and report delivery for both nonclinical and clinical study sample analysis
Support contracting for assay development and sample analysis, including development of statements of work and master services agreements with bioanalytical labs
Develop and validate key biomarker assays internally and at CROs for use on nonclinical and clinical trial biomarker samples, including scientific input on assay method development, and document review of plans and reports
Design, execute and interpret experiments to support and broaden the biological understanding of validated biomarker assays, and how the results reflect heart disease progression and response to gene therapy
Data analysis to validate and deepen insights from CRO-generated results of heart disease and immunogenicity biomarkers
Qualification
Required
A 4-yr degree in a relevant science with > 10 years relevant industry experience or MS with 6+ years' industry experience
Experience with clinical trial biomarker sample logistics and operation required, including sample database and inventory management
Experience with assay development and validation in multiple platforms, e.g., qPCR and ddPCR, LC-MS/MS, ligand binding assays, immunohistochemistry, microscopy, flow cytometry
Experience with management of CROs required
Knowledge and understanding of nonclinical and clinical trials and the role of biomarkers and translational medicine within those studies
The ability to manage multiple tasks efficiently, to communicate clearly and effectively, as well as to build open and collaborative relationships are essential
Ability to function well both independently and as part of a small, dedicated team
A positive attitude and strong attention to detail are required
Preferred
A background in cardiac biology and disease, genetic diseases, and/or cell or gene therapies preferred
Benefits
We offer a dynamic start-up environment and a collaborative, passionate team that is focused on a compelling vision and mission.
We offer competitive salary and stock options.
Excellent medical and non-medical benefits.
Paid vacation, sick time and holidays.
State-of-the-art, built-to-suit office and lab space, part of a larger cluster of biotech companies, with amenities that include a bowling alley and onsite gym.
Shuttle service to/from Caltrain, BART and the South San Francisco Ferry.
Company
Tenaya Therapeutics
Tenaya Therapeutics a clinical-stage biotechnology company that develops novel therapies to treat heart diseases.
51-200 employees
H1B Sponsorship
Tenaya Therapeutics has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (1)
2024 (1)
2023 (3)
2022 (2)
2021 (1)
2020 (3)
Funding
Current Stage
Public CompanyTotal Funding
$493.5MKey Investors
California Institute for Regenerative MedicineRTW InvestmentsCasdin Capital
2025-12-11Post Ipo Equity· $60M
2025-02-03Post Ipo Equity· $52.5M
2025-02-03Grant· $8M
Leadership Team
Faraz Ali
Chief Executive Officer
Bruce Conklin
Co-Founder
Recent News
2026-01-11
2025-12-16
2025-12-13
Company data provided by crunchbase